TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9881518

Group type: EXPERIMENTAL
Intervention: Selenium enriched yeast (4.8 mg containing 5 microg selenium daily via nasogastric drip during the first 14 postnatal days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonsupplemented (reference group)
Number of subjects: 28
Study: 7982105

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasonography after embolization with n-butyl cyanoacrylate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nonfeeding arteries (ipsilateral and contralateral)
Number of subjects: 8
Study: 2484663

Group type: EXPERIMENTAL
Intervention: Pirbuterol 0.2 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pirbuterol 0.4 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metaproterenol 1.3 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1242334

Group type: EXPERIMENTAL
Intervention: Instenon forte (hexobendine, etamivan, etofylline)
Number of subjects: 47
Study: 31009823

Group type: EXPERIMENTAL
Intervention: REsTRAIN YOURSELF intervention (Six Core Strategies)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control wards
Number of subjects: 291
Study: 26658237

Group type: EXPERIMENTAL
Intervention: PPX/RT
Number of subjects: 63

Group type: COMPARATOR
Intervention: TMZ/RT
Number of subjects: 63
Study: 26954779

Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (20 to 25 sessions of 45 minutes each at school)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Usual classroom teaching (control)
Number of subjects: 452
Study: 25242501

Group type: EXPERIMENTAL
Intervention: Human voices
Number of subjects: 38

Group type: COMPARATOR
Intervention: Baseline condition
Number of subjects: 38
Study: 22293363

Group type: EXPERIMENTAL
Intervention: Vitamin D3 4,000 IU daily for 12 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 20197426

Group type: EXPERIMENTAL
Intervention: Doubling the dose of ICS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding a leukotriene-receptor antagonist to the ICS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding a long-acting beta-agonist to the ICS
Number of subjects: 0
Study: 19160885

Group type: EXPERIMENTAL
Intervention: HES 6%
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: HES 10%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 44
Study: 15788369

Group type: COMPARATOR
Intervention: CYP3A4 mRNA in Japanese livers (n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CYP3A5 mRNA in Japanese (n = 9)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CYP3A7 mRNA in Japanese (n = 24)
Number of subjects: 48
Study: 12441749

Group type: EXPERIMENTAL
Intervention: HFOV plus iNO (n = 14)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: HFOV alone (n = 12)
Number of subjects: 108

Group type: COMPARATOR
Intervention: CMV plus iNO (n = 35)
Number of subjects: 108

Group type: COMPARATOR
Intervention: CMV alone (n = 38)
Number of subjects: 108
Study: 10385832

Group type: EXPERIMENTAL
Intervention: Health promotion programme addressing barriers to implementing the New Zealand Playground Safety Standard; included information about hazards, an engineer's report, regular contact and encouragement, and assistance in obtaining funding.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group received only information about hazards in their playground.
Number of subjects: 24
Study: 7728983

Group type: EXPERIMENTAL
Intervention: 300 g of cooked Brussels sprouts per day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no cruciferous vegetables)
Number of subjects: 10
Study: 1823147

Group type: EXPERIMENTAL
Intervention: Oral selenium plus copper associated with vitamin complex (tocopherol and retinol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7364691

Group type: EXPERIMENTAL
Intervention: Peer Tutoring Only
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Peer Tutoring with Home Based Reinforcement
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control
Number of subjects: 69
Study: 6860416

Group type: EXPERIMENTAL
Intervention: Once-daily tobramycin dosing
Number of subjects: 52

Group type: COMPARATOR
Intervention: Continuous infusion of tobramycin
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Once-daily dosing of gentamicin, tobramycin, or netilmicin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Continuous tobramycin dosing
Number of subjects: 52
Study: 31405899

Group type: EXPERIMENTAL
Intervention: Individually tailored rituximab regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed-schedule rituximab regimen
Number of subjects: 0
Study: 30133461

Group type: EXPERIMENTAL
Intervention: Training intervention for shared decision-making
Number of subjects: 604

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 604
Study: 26243629

Group type: EXPERIMENTAL
Intervention: Floseal + harmonic scalpel (HS)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Floseal alone
Number of subjects: 206

Group type: COMPARATOR
Intervention: HS alone
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard total thyroidectomy
Number of subjects: 206
Study: 24169960

Group type: EXPERIMENTAL
Intervention: Low-fat fish oil (LFFO) diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Western diet
Number of subjects: 0
Study: 23062276

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 117

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 117
Study: 21131037

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (4 mg infusion every 3-4 weeks)
Number of subjects: 1960

Group type: COMPARATOR
Intervention: Clodronic acid (1600 mg oral daily)
Number of subjects: 1960
Study: 17627194

Group type: EXPERIMENTAL
Intervention: Reiki touch therapy
Number of subjects: 0
Study: 15760966

Group type: EXPERIMENTAL
Intervention: GnRH agonist (buserelin) 0.5 mg s.c.
Number of subjects: 122

Group type: COMPARATOR
Intervention: hCG 10,000 IU
Number of subjects: 122
Study: 12211672

Group type: EXPERIMENTAL
Intervention: Exeter femoral stem
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elite Plus femoral stem
Number of subjects: 0
Study: 10476343

Group type: EXPERIMENTAL
Intervention: Alcoholic cardiomyopathy (ACMP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy (DCMP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (accident death)
Number of subjects: 20
Study: 8936778

Group type: EXPERIMENTAL
Intervention: Non-arteritic anterior ischemic optic neuropathy group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (sex and age matched)
Number of subjects: 37
Study: 1934552

Group type: EXPERIMENTAL
Intervention: Ear-canal magnets treatment
Number of subjects: 50
Study: 12760406

Group type: EXPERIMENTAL
Intervention: Tobramycin 2.5 mg/kg/12 hr for a mean of 8 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gentamicin 2.5 mg/kg/12 hr for a mean of 8 days
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tobramycin and Gentamicin
Number of subjects: 50
Study: 30787665

Group type: EXPERIMENTAL
Intervention: Vibration Foam Rolling (VFR)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-Vibration Foam Rolling (NVFR)
Number of subjects: 38
Study: 28576354

Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Conduction mattress warming
Number of subjects: 132

Group type: COMPARATOR
Intervention: No active body warming
Number of subjects: 132

Group type: COMPARATOR
Intervention: In-line intravenous fluid warming
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Neonatal core temperature
Number of subjects: 132
Study: 25708754

Group type: EXPERIMENTAL
Intervention: Combined needle and snare unit
Number of subjects: 140

Group type: COMPARATOR
Intervention: Spiral wire
Number of subjects: 140
Study: 24299621

Group type: EXPERIMENTAL
Intervention: Joint position error test
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cranio-cervical flexion test
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neck flexor muscle endurance test (supine)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neck flexor muscle endurance test (45°-upright)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neck extensor test
Number of subjects: 63
Study: 21261988

Group type: EXPERIMENTAL
Intervention: Health education intervention based on WHO's IMCI, consisting of eight monthly 30-minute sessions.
Number of subjects: 1855

Group type: COMPARATOR
Intervention: Control group (no health education intervention).
Number of subjects: 1855
Study: 19050692

Group type: EXPERIMENTAL
Intervention: Trans-rectal ultrasound (TRUS) for biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) or computed tomography (CT) for staging
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomograms developed from PSA, Gleason score, and clinical grading
Number of subjects: 0
Study: 17215658

Group type: EXPERIMENTAL
Intervention: HCTZ 50 mg/d
Number of subjects: 105

Group type: COMPARATOR
Intervention: HCTZ 25 mg/d
Number of subjects: 105

Group type: COMPARATOR
Intervention: OM 40 mg/d (monotherapy)
Number of subjects: 105
Study: 15066064

Group type: EXPERIMENTAL
Intervention: Cane
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ankle orthoses
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Touch of a vertical surface
Number of subjects: 42

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 42
Study: 14713367

Group type: EXPERIMENTAL
Intervention: sho‐saiko‐to (2.5 g twice daily for five days)
Number of subjects: 26
Study: 10084580

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) and oxandrolone (OX) in combination
Number of subjects: 46
Study: 7552095

Group type: EXPERIMENTAL
Intervention: Intravenous calcitriol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral calcitriol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily calcitriol administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent calcitriol administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physiologic dosing of calcitriol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacologic dosing of calcitriol
Number of subjects: 0
Study: 2048803

Group type: EXPERIMENTAL
Intervention: Smoking intervention program and prescription of an inhaled bronchodilator
Number of subjects: 5887

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 5887
Study: 7231338

Group type: EXPERIMENTAL
Intervention: Proglumid
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 70
Study: 30487565

Group type: EXPERIMENTAL
Intervention: Normal sleep and meal conditions
Number of subjects: 5

Group type: COMPARATOR
Intervention: Late sleep and meal conditions
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Normal sleep and late meal conditions
Number of subjects: 5

Group type: COMPARATOR
Intervention: Late sleep and normal meal conditions
Number of subjects: 5
Study: 29309388

Group type: EXPERIMENTAL
Intervention: Variable load (30% 1RM constant load and 15% 1RM variable load; chains)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Constant load (no chains)
Number of subjects: 8
Study: 26876144

Group type: EXPERIMENTAL
Intervention: Guided bone regeneration (GBR) using acellular dermal matrix film combined with alveolar bone grafting using iliac crest bone grafts
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional alveolar bone grafting only (non‐GBR group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between GBR and non-GBR groups
Number of subjects: 60
Study: 24203933

Group type: EXPERIMENTAL
Intervention: Smoking relapse-prevention intervention
Number of subjects: 504
Study: 22345878

Group type: EXPERIMENTAL
Intervention: Acamprosate 333 mg TDS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20423242

Group type: EXPERIMENTAL
Intervention: 10 microg estradiol vaginal tablets
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 25 microg estradiol vaginal tablets
Number of subjects: 58

Group type: COMPARATOR
Intervention: Comparison of 10 microg and 25 microg doses
Number of subjects: 58
Study: 18675392

Group type: EXPERIMENTAL
Intervention: Progressive and supervised 21-week concurrent strength and endurance training
Number of subjects: 26
Study: 15893183

Group type: EXPERIMENTAL
Intervention: Home Telemonitoring (HTM)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Nurse Telephone Support (NTS)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 426
Study: 12637127

Group type: EXPERIMENTAL
Intervention: Inhaled formoterol dry powder 12 microg BID
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 40 microg QID
Number of subjects: 780

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 780
Study: 11036957

Group type: EXPERIMENTAL
Intervention: Intraportal chemotherapy (5‐fluorouracil 500 mg/m2/day in continuous infusion for 7 days and mitomycin C 10 mg/m2 at day 7)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group (systemic chemotherapy only)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Intraportal chemotherapy
Number of subjects: 260
Study: 8869649

Group type: EXPERIMENTAL
Intervention: Inhaled anesthetics
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Local-regional anesthetic procedures (axilar blocks and local infiltrations)
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: High abdominal surgery
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Lower abdominal surgery
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Perineal surgery
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: ASA III classification, procedures lasting longer than 120 minutes, upper abdominal surgery, isoflurane and pancuronium use, adverse events
Number of subjects: 1227
Study: 1325176

Group type: EXPERIMENTAL
Intervention: Low dose natural interferon alfa (nIFN‐alpha)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy (CAP)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control (no maintenance treatment)
Number of subjects: 237
Study: 6151145

Group type: EXPERIMENTAL
Intervention: Ceruletide (40 micrograms, intramuscularly, twice for 2 consecutive weeks)
Number of subjects: 6
Study: 29792582

Group type: EXPERIMENTAL
Intervention: Enough! training (1-hour online course)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (Group B, posttest only)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (Group C, pre- and posttests)
Number of subjects: 134
Study: 28914750

Group type: EXPERIMENTAL
Intervention: Live-attenuated influenza vaccine (LAIV)
Number of subjects: 1151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1151
Study: 27095323

Group type: EXPERIMENTAL
Intervention: Cost-benefit intervention with Professional e-coach (CB Pro)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cost-benefit intervention with Peer e-coach (CB Peer)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard arm (traditional weight maintenance strategies)
Number of subjects: 75
Study: 25363100

Group type: EXPERIMENTAL
Intervention: Supportive supervision in intervention districts
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group (no supportive supervision)
Number of subjects: 340
Study: 21786162

Group type: EXPERIMENTAL
Intervention: Hay + 150 g moringa leaf (T2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hay + 300 g moringa leaf (T3)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hay + 450 g moringa leaf (T4)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rhodes grass hay (T1)
Number of subjects: 24
Study: 20522670

Group type: EXPERIMENTAL
Intervention: Methoxy polyethylene glycol‐epoetin beta
Number of subjects: 490

Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 490
Study: 18616066

Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Visitor (partial intervention)
Number of subjects: 237
Study: 16097539

Group type: EXPERIMENTAL
Intervention: Pressurization of cement
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fingerpacking of cement
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall group
Number of subjects: 50
Study: 12583554

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (2.2 g)
Number of subjects: 511

Group type: COMPARATOR
Intervention: Cefazolin (2 g)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Amoxicillin‐clavulanic acid (2.2 g) and Cefazolin (2 g)
Number of subjects: 511
Study: 10626237

Group type: EXPERIMENTAL
Intervention: Clofazimine 50 mg daily for six months in addition to the WHO regimen
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group receiving standard WHO regimen (six doses of once a month rifampicin with daily dapsone for six months)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Clofazimine containing regimen
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study: 7582283

Group type: EXPERIMENTAL
Intervention: Children with high serum IgE levels (highest tertile)
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Asthmatic parents with moderate serum IgE levels
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Asthmatic children
Number of subjects: 1177

Group type: COMPARATOR
Intervention: General population
Number of subjects: 1177
Study: 8151095

Group type: EXPERIMENTAL
Intervention: Vasopressin plus Nicardipine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vasopressin alone
Number of subjects: 18
Study: 3636818

Group type: EXPERIMENTAL
Intervention: Z‐track intramuscular injection technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard injection technique
Number of subjects: 50
Study: 29625016

Group type: EXPERIMENTAL
Intervention: Reliving or having an inspirational experience
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reporting inspirational experiences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Being inspired by someone or something
Number of subjects: 0
Study: 27086768

Group type: EXPERIMENTAL
Intervention: Vitamin E‐fortified whey beverage (15g of whey protein concentrate + 600IU of vitamin E)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Whey beverage (15g of whey protein concentrate)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Vitamin E (600IU)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 92
Study: 27101668

Group type: EXPERIMENTAL
Intervention: Nasal endoscope negative pressure cleaning and sinupret drops
Number of subjects: 153

Group type: COMPARATOR
Intervention: Nasal endoscope negative pressure cleaning and normal saline spray washing
Number of subjects: 153

Group type: COMPARATOR
Intervention: Saline nasal irrigation through nasal catheter
Number of subjects: 153
Study: 23282127

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg per day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 22043464

Group type: EXPERIMENTAL
Intervention: Short implants (5 to 8.5 mm)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Bone augmentation with autogenous bone for longer implants (>11.5 mm)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups (short implants and augmented longer implants)
Number of subjects: 28
Study: 19916291

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus moxibustion (EA-Moxi)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication with Omeperazole (20 mg, qd.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quality of life measures (SF-36 questionnaire) in EA-Moxi group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quality of life measures (SF-36 questionnaire) in both groups
Number of subjects: 60
Study: 16954725

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 34
Study: 15026292

Group type: EXPERIMENTAL
Intervention: Moms on the Move (PA intervention)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Counseling on self‐breast examination (control)
Number of subjects: 44
Study: 11297595

Group type: EXPERIMENTAL
Intervention: Troglitazone 300 mg/day (TGZ-300)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Troglitazone 600 mg/day (TGZ-600)
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Troglitazone (all doses)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 410
Study: 9508155

Group type: EXPERIMENTAL
Intervention: Active treatment with chlorthalidone (12.5-25 mg/d)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 8070930

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (33.3/16.7 mg/kg bodyweight)
Number of subjects: 21
Study: 3144172

Group type: EXPERIMENTAL
Intervention: Lipid-based TPN (70% CHO, 30% lipid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbohydrate-based TPN (100% CHO)
Number of subjects: 0
Study: 29989014

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 120
Study: 27580827

Group type: EXPERIMENTAL
Intervention: Social facilitation maintenance treatment (4 months, 16 outpatient group sessions)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Social facilitation maintenance treatment
Number of subjects: 72
Study: 24732860

Group type: EXPERIMENTAL
Intervention: Strengthening exercises
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Flexibility exercises
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Strengthening exercises with abdominal bracing
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Flexibility exercises with abdominal bracing
Number of subjects: 600

Group type: COMPARATOR
Intervention: Non-bracing groups (Strengthening and Flexibility)
Number of subjects: 600